Lotepred T Eye Drop is a combination ophthalmic solution containing Loteprednol etabonate 0.5% w/v, a corticosteroid with potent anti-inflammatory properties, and Tobramycin 0.3% w/v, a broad-spectrum aminoglycoside antibiotic. This formulation is indicated for the treatment of inflammatory ocular conditions where a bacterial infection or risk of bacterial contamination is present, such as allergic conjunctivitis, postoperative inflammation, and bacterial conjunctivitis. Loteprednol etabonate acts by inhibiting the release of inflammatory mediators, thereby reducing redness, swelling, and discomfort, while Tobramycin effectively eradicates susceptible gram-negative and gram-positive bacterial pathogens. The combination offers dual therapeutic benefits by addressing both inflammation and infection simultaneously, minimizing the need for multiple medications. Lotepred T Eye Drop is typically administered as one or two drops into the affected eye(s) every four to six hours, or as directed by a healthcare professional. Caution is advised in patients with a history of hypersensitivity to corticosteroids or aminoglycosides, and prolonged use should be avoided to reduce the risk of corticosteroid-induced ocular side effects such as increased intraocular pressure or cataract formation. Proper hygiene and adherence to prescribed dosing are essential to ensure optimal therapeutic outcomes.